Author

E. Maurizi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Merra· 2 shared C. Macaluso· 2 shared D. Schiroli· 2 shared G. Pellegrini· 2 shared C. Chiappini· 1 shared D. A. Martella· 1 shared S. A. Mustfa· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. Merra

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GSK3 inhibition reverts mesenchymal transition in human primary corneal endothelial cells

E. Maurizi, A. Merra, C. Macaluso, D. Schiroli, G. Pellegrini

This study shows that GSK3 inhibition with CHIR99021 prevents mesenchymal transition in human corneal endothelial cells, preserving their morphology and phenotype.

bioRxiv · Nov 25, 2022 · PreprintCell Biology

Nanoneedles for targeted siRNA silencing of p16 in the Human Corneal Endothelium

E. Maurizi, D. A. Martella, D. Schiroli, A. Merra, S. A. Mustfa, G. Pellegrini, C. Macaluso, C. Chiappini

This study demonstrates that nanoneedles can deliver p16-targeting siRNA to human corneal endothelial cells, inducing p16 silencing and increasing cell proliferation without toxicity.

bioRxiv · May 27, 2022 · PreprintBioengineering